FDA PMA FDA Class 3 Approved 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

PMA: P110016 · Supplement: S073 · Decision Mar 12, 2021
Classifications
1
FEI Numbers
46
Registration Numbers
46

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter
Trade Name
Therapy Cool Path Duo, Safire BLU Duo, Cool Path, Duo, Safire Duo, Therapy Cool Path Duo SP, Safire, BLU Duo SP and Ther
PMA Number
P110016
Supplement Number
S073
Device Class
FDA Class 3
Product Code
OAD
Generic Name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 12, 2021
Date Received
January 13, 2021
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

Approval for minor design changes to a printed circuit board assembly and a change in supplier for the manufacture of the printed circuit board assembly.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAD Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter